AbbVie Inc.ABBVNYSE
LOADING
|||
Revenue Growth Under Pressure
Trending lower, below historical average, slight contraction.
Left:
||||
Year-over-year revenue growth rate
Latest
2.29%
↓ 19% below average
Average (39q)
2.83%
Historical baseline
Range
High:23.76%
Low:-19.15%
CAGR
-3.1%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 2.29% |
| Q2 2025 | 15.59% |
| Q1 2025 | -11.65% |
| Q4 2024 | 4.44% |
| Q3 2024 | -0.01% |
| Q2 2024 | 17.48% |
| Q1 2024 | -13.92% |
| Q4 2023 | 2.69% |
| Q3 2023 | 0.45% |
| Q2 2023 | 13.42% |
| Q1 2023 | -19.15% |
| Q4 2022 | 2.09% |
| Q3 2022 | 1.57% |
| Q2 2022 | 7.72% |
| Q1 2022 | -9.06% |
| Q4 2021 | 3.79% |
| Q3 2021 | 2.74% |
| Q2 2021 | 7.29% |
| Q1 2021 | -6.12% |
| Q4 2020 | 7.41% |
| Q3 2020 | 23.76% |
| Q2 2020 | 20.95% |
| Q1 2020 | -0.98% |
| Q4 2019 | 2.65% |
| Q3 2019 | 2.71% |
| Q2 2019 | 5.45% |
| Q1 2019 | -5.74% |
| Q4 2018 | 0.84% |
| Q3 2018 | -0.51% |
| Q2 2018 | 4.34% |
| Q1 2018 | 2.52% |
| Q4 2017 | 10.64% |
| Q3 2017 | 0.73% |
| Q2 2017 | 6.21% |
| Q1 2017 | -3.80% |
| Q4 2016 | 5.66% |
| Q3 2016 | -0.31% |
| Q2 2016 | 8.29% |
| Q1 2016 | -6.91% |
| Q4 2015 | 7.67% |